Lithium Hydroxide → (R)-4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-((1S,4S)-2,2-dioxido-2-thia-5-azabicyclo[2.2.1]heptan-5-yl)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)cyclohex-3-enecarboxylic acid
Reaction equation
[O:1]=[S:2]1(=[O:57])[CH2:7][C@@H:6]2[CH2:8][C@H:3]1[CH2:4][N:5]2[CH2:9][CH2:10][NH:11][C@:12]12[CH2:53][CH2:52][C@@H:51]([C:54]([CH3:56])=[CH2:55])[C@@H:13]1[C@@H:14]1[C@@:27]([CH3:30])([CH2:28][CH2:29]2)[C@@:26]2([CH3:31])[C@@H:17]([C@:18]3([CH3:50])[C@@H:23]([CH2:24][CH2:25]2)[C:22]([CH3:33])([CH3:32])[C:21]([C:34]2[CH2:39][CH2:38][C@@H:37]([C:40]([O:42]CC4C=CC=CC=4)=[O:41])[CH2:36][CH:35]=2)=[CH:20][CH2:19]3)[CH2:16][CH2:15]1.[OH-].[Li+]>C1COCC1.CO>[O:57]=[S:2]1(=[O:1])[CH2:7][C@@H:6]2[CH2:8][C@H:3]1[CH2:4][N:5]2[CH2:9][CH2:10][NH:11][C@:12]12[CH2:53][CH2:52][C@@H:51]([C:54]([CH3:56])=[CH2:55])[C@@H:13]1[C@@H:14]1[C@@:27]([CH3:30])([CH2:28][CH2:29]2)[C@@:26]2([CH3:31])[C@@H:17]([C@:18]3([CH3:50])[C@@H:23]([CH2:24][CH2:25]2)[C:22]([CH3:32])([CH3:33])[C:21]([C:34]2[CH2:39][CH2:38][C@@H:37]([C:40]([OH:42])=[O:41])[CH2:36][CH:35]=2)=[CH:20][CH2:19]3)[CH2:16][CH2:15]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 75 °C
Procedure
To a solution of (R)-benzyl 4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-((1S,4S)-2,2-dioxido-2-thia-5-azabicyclo[2.2.1]heptan-5-yl)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)cyclohex-3-enecarboxylate (65.2 mg, 0.082 mmol) in THF (1.5 mL) and MeOH (0.5 mL) was added 3N lithium hydroxide (0.136 mL, 0.409 mmol). The reaction mixture was stirred at 75° C. for 3 h and then cooled to rt. The reaction content was subjected to reverse phase HPLC purification using prep-HPLC method 6 and dried under vacuum to give (R)-4-((1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-3a-((2-((1S,4S)-2,2-dioxido-2-thia-5-azabicyclo[2.2.1]heptan-5-yl)ethyl)amino)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-2,3,3a,4,5,5a,5b,6,7,7a,8,11,11a,11b,12,13,13a,13b-octadecahydro-1H-cyclopenta[a]chrysen-9-yl)cyclohex-3-enecarboxylic acid (48.2 mg, 0.049 mmol, 59.9% yield) as a white solid. LC/MS: m/e 707.5 (M+H)+, 4.07 min (method 8). 1H NMR (400 MHz, 1:1 CDCl3:METHANOL-d4) δ 5.33 (br. s., 1H), 5.21-5.13 (m, 1H), 4.77 (s, 1H), 4.70 (s, 1H), 3.98 (br. s., 1H), 3.64 (br. s., 1H), 3.40-3.34 (m, 1H), 3.30-3.24 (m, 1H), 3.16 (dd, J=11.4, 3.8 Hz, 2H), 3.11-3.05 (m, 2H), 3.05-2.94 (m, 2H), 2.83-2.70 (m, 1H), 2.58 (d, J=12.2 Hz, 1H), 2.48 (ddt, J=17.4, 6.1, 2.9 Hz, 1H), 2.44-2.36 (m, 1H), 2.32-2.22 (m, 2H), 2.21-2.12 (m, 2H), 2.11-2.04 (m, 2H), 2.03-1.91 (m, 5H), 1.87-1.72 (m, 3H), 1.71 (s, 3H), 1.68-1.53 (m, 5H), 1.52-1.37 (m, 7H), 1.34 (s, 1H), 1.32-1.23 (m, 1H), 1.09 (s, 3H), 1.05 (s, 3H), 0.95 (s, 3H), 0.93 (s, 3H), 0.87 (s, 3H).
Workup
- temperaturecooled to rt
- customphase HPLC purification
- customdried under vacuum
Sources & evidence
- ORD record
- ord-30bdd7c7055c4a32bc75f0dcad71ed0f
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08889854B2
Reaction notes
Loading…